2020 annual financial data
Neuphoria Therapeutics 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -8,364.92%.
Operating income was -6.19M USD and net income was -4.89M USD.
Operating cash flow was -2.68M USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 32,062 USD
- Operating income
- -6.19M USD
- Net income
- -4.89M USD
- Operating cash flow
- -2.68M USD